285 related articles for article (PubMed ID: 9987091)
1. Hyaluronan decreases peritoneal fluid absorption: effect of molecular weight and concentration of hyaluronan.
Wang T; Cheng HH; Heimbürger O; Chen C; Waniewski J; Bergström J; Lindholm B
Kidney Int; 1999 Feb; 55(2):667-73. PubMed ID: 9987091
[TBL] [Abstract][Full Text] [Related]
2. Intraperitoneal addition of hyaluronan improves peritoneal dialysis efficiency.
Wang T; Cheng HH; Heimbürger O; Chen C; Waniewski J; Bergström J; Lindholm B
Perit Dial Int; 1999; 19 Suppl 2():S106-11. PubMed ID: 10406503
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronan prevents the decreased net ultrafiltration caused by increased peritoneal dialysate fill volume.
Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
Kidney Int; 1998 Feb; 53(2):496-502. PubMed ID: 9461112
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronan preserves peritoneal membrane transport properties.
Guo QY; Peng WX; Cheng HH; Ye RG; Lindholm B; Wang T
Perit Dial Int; 2001; 21(2):136-42. PubMed ID: 11330556
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronan decreases peritoneal fluid absorption in peritoneal dialysis.
Wang T; Chen C; Heimbürger O; Waniewski J; Bergström J; Lindholm B
J Am Soc Nephrol; 1997 Dec; 8(12):1915-20. PubMed ID: 9402094
[TBL] [Abstract][Full Text] [Related]
6. High peritoneal residual volume decreases the efficiency of peritoneal dialysis.
Wang T; Cheng HH; Heimbürger O; Bergström J; Lindholm B
Kidney Int; 1999 May; 55(5):2040-8. PubMed ID: 10231469
[TBL] [Abstract][Full Text] [Related]
7. Effect of increased dialysate fill volume on peritoneal fluid and solute transport.
Wang T; Heimbürger O; Cheng H; Waniewski J; Bergström J; Lindholm B
Kidney Int; 1997 Oct; 52(4):1068-76. PubMed ID: 9328947
[TBL] [Abstract][Full Text] [Related]
8. Effect of peritonitis on peritoneal transport characteristics: glucose solution versus polyglucose solution.
Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
Kidney Int; 2000 Apr; 57(4):1704-12. PubMed ID: 10760106
[TBL] [Abstract][Full Text] [Related]
9. Dialysis solution containing hyaluronan: effect on peritoneal permeability and inflammation in rats.
Połubinska A; Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Chen C; Moberly JB; Martis L; Breborowicz A; Oreopoulos DG
Kidney Int; 2000 Mar; 57(3):1182-9. PubMed ID: 10720971
[TBL] [Abstract][Full Text] [Related]
10. Amphotericin B does not increase peritoneal fluid removal.
Wang T; Heimbürger O; Cheng HH; Bergström J; Lindholm B
Adv Perit Dial; 1998; 14():3-10. PubMed ID: 10649681
[TBL] [Abstract][Full Text] [Related]
11. Peritoneal fluid and solute transport with different polyglucose formulations.
Wang T; Heimbürger O; Cheng HH; Bergström J; Lindholm B
Perit Dial Int; 1998; 18(2):193-203. PubMed ID: 9576369
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal hyaluronan administration in conscious rats: absorption, metabolism, and effects on peritoneal fluid dynamics.
Breborowicz A; Polubinska A; Pawlaczyk K; Kuzlan-Pawlaczyk M; Moberly J; Martis L; Oreopoulos D
Perit Dial Int; 2001; 21(2):130-5. PubMed ID: 11330555
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal fluid kinetics: comparison between polyglucose solution and albumin solution.
Wang T; Cheng HH; Heimbürger O; Bergström J; Lindholm B
Adv Perit Dial; 1999; 15():21-7. PubMed ID: 10682066
[TBL] [Abstract][Full Text] [Related]
14. Intraperitoneal atrial natriuretic peptide increases peritoneal fluid and solute removal.
Wang T; Cheng HH; Heimbürger O; Chen C; Bergström J; Lindholm B
Kidney Int; 2001 Aug; 60(2):513-9. PubMed ID: 11473634
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronan and peritoneal ultrafiltration: a test of the "filter-cake" hypothesis.
Rosengren BI; Carlsson O; Rippe B
Am J Kidney Dis; 2001 Jun; 37(6):1277-85. PubMed ID: 11382699
[TBL] [Abstract][Full Text] [Related]
16. Vasodilatation by intraperitoneal addition of nitroprusside is not a model for high peritoneal transport.
Wang T; Cheng HH; Heimbürger O; Bergström J; Lindholm B
Adv Perit Dial; 1999; 15():53-9. PubMed ID: 10682072
[TBL] [Abstract][Full Text] [Related]
17. Effects of intraperitoneal hyaluronan on peritoneal fluid and solute transport in peritoneal dialysis patients.
Moberly JB; Sorkin M; Kucharski A; Ogle K; Mongoven J; Skoufos L; Lin L; Bailey S; Rodela H; Mupas L; Walele A; Ogrinc F; White D; Wolfson M; Martis L; Breborowicz A; Oreopoulos DG
Perit Dial Int; 2003; 23(1):63-73. PubMed ID: 12691509
[TBL] [Abstract][Full Text] [Related]
18. Fluid and solute transport using different sodium concentrations in peritoneal dialysis solutions.
Cheng HH; Wang T; Heimbürger O; Bergström J; Lindholm B
Perit Dial Int; 2001; 21(1):65-71. PubMed ID: 11280498
[TBL] [Abstract][Full Text] [Related]
19. Physiological saline is not a biocompatible peritoneal dialysis solution.
Wang T; Heimbürger O; Qureshi AR; Waniewski J; Bergström J; Lindholm B
Int J Artif Organs; 1999 Feb; 22(2):88-93. PubMed ID: 10212043
[TBL] [Abstract][Full Text] [Related]
20. Lyphatic absorption in CAPD patients with loss of ultrafiltration capacity.
Heimbürger O; Waniewski J; Werynski A; Park MS; Lindholm B
Blood Purif; 1995; 13(6):327-39. PubMed ID: 8821197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]